Our study on the risk of long-term consequences of COVID-19 in IMID patients has just been published in Gastro Hep Advances.

We report an increased risk of long-term consequences of COVID-19 in patients with IMIDs compared to their non-IMID counterparts. Spondyloarthritis, rheumatoid arthritis and psoriasis were individually associated with an increased risk.